Company / Depreciation & Amortization
ANI Pharmaceuticals, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$91.4M
FY2025
5-year range
$47.3M / $91.4M
FY2021-FY2025
Trend
+35.0%
vs FY2024
Sector context
#21 of 168
Health Care
What the data says
ANI Pharmaceuticals, Inc.'s depreciation & amortization of $91M is higher than 88% of companies in the Health Care sector (FY2025). Depreciation & Amortization has increased for 9 consecutive years, from $22M in FY2016 to $91M in FY2025.
Based on SEC 10-K filings.
$91M in FY2025 with a 5-year CAGR of +15.4%. Top quartile in the Health Care sector.
Increased from $60M to $91M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +17.1%
- 5-Year CAGR
- +15.4%
- 10-Year CAGR
- -
Sector benchmark
-57.1% below sector average
Key checks
Key Insights
- ANI Pharmaceuticals, Inc.'s depreciation & amortization has grown for 9 consecutive years.
- 5-year CAGR of +15.4%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 35.0% year-over-year.
- Ranks #21 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $91.4M | +35.0% |
| FY2024 | $67.7M | +13.3% |
| FY2023 | $59.8M | +4.9% |
| FY2022 | $57.0M | +20.6% |
| FY2021 | $47.3M | +5.9% |
| FY2020 | $44.6M | +0.1% |
| FY2019 | $44.6M | +32.2% |
| FY2018 | $33.7M | +20.8% |
| FY2017 | $27.9M | +25.0% |
| FY2016 | $22.3M | +1912.9% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026